Moreover, our analysis highlighted STC2's prognostic significance, with its overexpression correlating with poor disease-free interval (DFI), progression-free interval (PFI), and disease-specific survival (DSS) in CRC patients. The gene discussed is STC2; the disease is colorectal carcinoma.